Projects per year
Search results
-
Active
Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Kapoor, M. (Primary Chief Investigator (PCI))
5/12/24 → 4/12/26
Project: Research
-
Finished
Australian CIDP National Registry: Dissecting Phenotypes and Immunoglobulin Usage Requirements
Park, S. B. (Primary Chief Investigator (PCI)), Kapoor, M. (Chief Investigator (CI)), Henderson, R. D. (Chief Investigator (CI)), Garg, N. (Chief Investigator (CI)), Lin, C. S. Y. (Chief Investigator (CI)), Vucic, O. (Chief Investigator (CI)), Barnett, M. H. (Chief Investigator (CI)), Street, D. J. (Chief Investigator (CI)), Goodall, S. (Chief Investigator (CI)), Kiernan, M. C. (Chief Investigator (CI)), Taylor, B. V. (Chief Investigator (CI)), Bellgard, M. (Chief Investigator (CI)) & Kiers, L. (Chief Investigator (CI))
1/05/22 → 30/04/25
Project: Research